Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin gets USFDA nod for Prednisolone Acetate Ophthalmic Suspension USP
Lupin was granted a Competitive Generic Therapy designation (CGT) for this product, and being the first approved applicant, Lupin…
DoP implements PLI scheme for pharmaceuticals with a financial outlay of Rs 15,000 cr
The scheme provides a financial incentive to 55 selected applicants for manufacturing of identified products under three…
FDA approves gene therapy to treat adults with Metastatic Synovial Sarcoma
Among the 44 patients in the trial who received Tecelra, the overall response rate was 43.2 per cent and the median duration of…
DIA’s India Annual Meeting to host discussions on evolving regulatory landscape
Subcontinent's regulators and stakeholders to also discuss patient safety, compliance, advanced therapies, and the impact of…
Unleashing the future of drug discovery with generative AI
In an exclusive interview, Kapil Mehta, Senior Director, Technology Solutions, Visionet, discusses how generative AI is…
ENTOD Pharmaceuticals appoints Prof Vivek Padgaonkar as non-executive independent director
Former OPPI Director joins ENTOD’s board, bringing expertise in pharma policy and innovation
Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Arranon Injection, 250 mg/50 mL (5…
Finding the right balance for nutraceuticals
If nutraceuticals shift from FSSAI to CDSCO, they will also come under price control. While this is good for consumers, industry…
Parexel releases 2023 Environmental, Social and Governance report
The report outlines Parexel’s advancements in sustainable practices, diversity, patient engagement, and operational integrity
Greg Smith appointed New Director of U.S. FDA India office
New leadership aims to continue strengthening the safety of medical products and food in India